The results showed that DNAJB11, EIF4A2, and SERP1 had copy number increases in ESCC, whereas EXOSC10, ZBTB17, and EXTL1 showed copy number loss in LIHC and rectal cancer, as shown in Figure 1B. Here, EIF4A2 is linked to rectal cancer.